FDA Panel Narrowly Endorses Bone Graft Device‎

An FDA advisory panel narrowly recommended approval for an investigational bone graft device that uses a growth factor protein to regrow bones in the foot and ankle. The device is called Augment and is made by BioMimetic, which is seeking approval for the device to be an alternative to harvesting a patient's own bone for the fusion procedure.